Anti-ageing drug breakthrough

March 8, 2013

Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The work, published in the March 8 issue of Science, finally proves that a single anti-ageing enzyme in the body can be targeted, with the potential to prevent age-related diseases and extend lifespans.

The paper shows all of the 117 drugs tested work on the single enzyme through a common mechanism. This means that a whole new class of anti-ageing drugs is now viable, which could ultimately prevent cancer, Alzheimer's disease and .

"Ultimately, these drugs would treat one disease, but unlike drugs of today, they would prevent 20 others," says the lead author of the paper, Professor David Sinclair, from UNSW Medicine, who is based at Harvard University. "In effect, they would slow ageing."

The target enzyme, SIRT1, is switched on naturally by and exercise, but it can also be enhanced through activators. The most common naturally-occurring activator is resveratrol, which is found in small quantities in , but synthetic activators with much stronger activity are already being developed.

Although research surrounding resveratrol has been going for a decade, until now the basic science had been contested. Despite this, there have already been promising results in some trials with implications for cancer, cardiovascular disease and , type 2 diabetes, Alzheimer's and Parkinson's diseases, , cataracts, osteoporosis, muscle wasting, and such as psoriasis, arthritis and colitis ().

"In the history of pharmaceuticals, there has never been a drug that tweaks an enzyme to make it run faster," says Professor Sinclair, a geneticist with the Department of Pharmacology at UNSW.

The technology was sold to pharmaceutical giant in 2008. Four thousand synthetic activators, which are 100 times as potent as a single glass of red wine, have been developed – the best three are in human trials.

"Our drugs can mimic the benefits of diet and exercise, but there is no impact on weight," says Professor Sinclair, who suggests the first therapeutic to be marketed will be for diabetes.

There have been limited trials in people with type 2 diabetes and the skin inflammatory disease, psoriasis. There were benefits to the metabolism in the first group and a reduction in skin redness in the second.

The drugs can be administered orally, or topically. So far, there have been no drugs developed targeting ageing skin, but one major skin care range has developed a crème with resveratrol in it.

While any drug would be strictly prescribed for certain conditions, Professor Sinclair suggests that one day, they could be taken orally as a preventative. This would be in much the same way as statin drugs are commonly prescribed to prevent, instead of simply treating, cardiovascular disease.

In animal models, overweight mice given synthetic were able to run twice as far as slim mice and they lived 15 per cent longer.

"Now we are looking at whether there are benefits for those who are already healthy. Things there are also looking promising," says Professor Sinclair, who also heads the Lowy Cancer Research Centre's Laboratory for Ageing Research at UNSW.

"We're finding that ageing isn't the irreversible affliction that we thought it was," he says. "Some of us could live to 150, but we won't get there without more research."

Explore further: 3 Questions: MIT biologist on new resveratrol study

Related Stories

3 Questions: MIT biologist on new resveratrol study

March 7, 2013
In the early 1990s, MIT professor Leonard Guarente discovered that sirtuins, a class of proteins found in nearly all animals, protect against the effects of aging in yeast; similar effects have since been seen in many other ...

New study validates longevity pathway: Findings identify universal mechanism for activating anti-aging pathway

March 7, 2013
A new study demonstrates what researchers consider conclusive evidence that the red wine compound resveratrol directly activates a protein that promotes health and longevity in animal models. What's more, the researchers ...

More evidence for longevity pathway

May 1, 2012
New research reinforces the claim that resveratrol—a compound found in plants and food groups, notably red wine—prolongs lifespan and health-span by boosting the activity of mitochondria, the cell's energy supplier.

Recommended for you

Lactation hormone also helps a mother's brain

September 26, 2017
The same hormone that stimulates milk production for lactation, also acts in the brain to help establish the nurturing link between mother and baby, University of Otago researchers have revealed for the first time.

Image ordering often based on factors other than patient need: study

September 25, 2017
Do you really need that MRI?

Bone marrow concentrate improves joint transplants

September 25, 2017
Biologic joint restoration using donor tissue instead of traditional metal and plastic may be an option for active patients with joint defects. Although recovery from a biologic joint repair is typically longer than traditional ...

Researchers describe mechanism that underlies age-associated bone loss

September 22, 2017
A major health problem in older people is age-associated osteoporosis—the thinning of bone and the loss of bone density that increases the risk of fractures. Often this is accompanied by an increase in fat cells in the ...

Researchers develop treatment to reduce rate of cleft palate relapse complication

September 22, 2017
Young people with cleft palate may one day face fewer painful surgeries and spend less time undergoing uncomfortable orthodontic treatments thanks to a new therapy developed by researchers from the UCLA School of Dentistry. ...

Exosomes are the missing link to insulin resistance in diabetes

September 21, 2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

DGBEACH
5 / 5 (1) Mar 08, 2013
"Once again the powers that be have raised the official age for partial retirement to 115, and complete retirement based upon genetic predisposition. Mankind's lifespan has now been pushed to 227 years, and continues to expand. And on a different note, 185 year old George Bush has just announced his intention to run for president again. If elected, this would be President Bush's 5th round in the White house. When asked to comment, he simply stated "I feel great, never been better...and this time we're gonna find those weapons of mass destruction!" "
Mannstein
4 / 5 (1) Mar 09, 2013
I'm surprised the CIA didn't plant WMD in Iraq so Bush could claim I told you so.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.